Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators - Wikidata - awgldk - TriplyDB

Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators

Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators

http://www.wikidata.org/entity/Q28143758

about

PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer Quantitative proteomics of the thyroid hormone receptor-coregulator interactions The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention Breaking the mold: transcription factors in the anucleate platelet and platelet-derived microparticles Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases Commonalities in the Association between PPARG and Vitamin D Related with Obesity and Carcinogenesis RB18A regulates p53-dependent apoptosis Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade Examination of Ligand-Dependent Coactivator Recruitment by Peroxisome Proliferator-Activated Receptor-alpha (PPARalpha).Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.Transcriptional regulation of the mouse steroid 5alpha-reductase type II gene by progesterone in brain Minireview: Challenges and opportunities in development of PPAR agonists Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.Ligand-binding regulation of LXR/RXR and LXR/PPAR heterodimerizations: SPR technology-based kinetic analysis correlated with molecular dynamics simulation.The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic-acid methyl ester has potent anti-diabetic effects in diet-induced diabetic mice and Lepr(db/db) mice Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis.Differentiating members of the thiazolidinedione class: a focus on efficacy.Novel insulin sensitizers: pharmacogenomic aspects.PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting PPAR and immune system--what do we know?Differential regulation of SF-1-cofactor interactions.An essential function of the SRC-3 coactivator in suppression of cytokine mRNA translation and inflammatory response.PPARgamma: a novel molecular target in lung disease.Association of NCOA2 gene polymorphisms with obesity and dyslipidemia in the Chinese Han population The role of peroxisome proliferator-activated receptors in pulmonary vascular disease.Relationship between Single Nucleotide Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Gene and Fatty Acid Composition in Korean Native Cattle Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells.15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-gamma Agonists A Novel Mechanism of PPARgamma Regulation of TGFbeta1: Implication in Cancer Biology Nuclear Receptor Cofactors in PPARgamma-Mediated Adipogenesis and Adipocyte Energy Metabolism.Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer types Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator.PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury.Identification and regulation of novel PPAR-gamma splice variants in human THP-1 macrophages Leanness and heightened nonresting energy expenditure: role of skeletal muscle activity thermogenesis.PPARgamma as a potential therapeutic target in pulmonary hypertension.Peroxisome proliferator-activated receptor gamma in osteoarthritis.Effects of PPARγ Ligands on Leukemia.Examining the safety of PPAR agonists - current trends and future prospects.

P2860

Q21328702-14547797-7310-4436-B55C-385344BB09CF Q24337435-74F9AA26-8AC1-49C8-B45F-97592F243A9F Q24601222-880D5CB6-2E9B-498A-A7F9-0EEB7D104723 Q26830366-EDDDD642-194E-488A-AFCA-5C5045C92BF5 Q27025212-C340BCB7-6EF6-463A-B2A3-820E39AFA393 Q28070220-2DCDD44B-831F-4283-A7BA-E38EC7B61010 Q28200741-66940D9E-5458-4F02-A666-B24EAC3B6758 Q28211233-B237BE63-0F53-44E5-A450-1B054D0CAB20 Q33270648-51FFDF2B-D32B-4CFC-BB64-BFC0FDD2517B Q33318963-6DD26EE6-4932-4D65-B9F9-C1D184893336 Q33587653-3FA43920-DCB0-4030-A36F-C3E1AE741318 Q33631921-1C96B348-A80F-4776-9B80-89818EB5D6ED Q33967999-0BCB1016-7FC7-4696-A4EA-EB85BD8FFAAB Q34396236-340A9AFD-FF88-455B-ABFB-9CB1F6240B84 Q34412580-CDC6DB8A-2144-4C83-BD01-AC41F9923480 Q34483124-840EC35C-BC78-4796-91D3-12A6220CD194 Q34580989-02090D8C-7B3D-4FE9-8C99-91EC3A2B55EF Q34609164-09FB6EC7-CDF6-47C9-9BCC-CFD1ABEE3BA2 Q34652034-F6CDC80A-95C2-4C8A-84B7-A64D565CC71B Q34913467-A45F6F3E-02C5-4152-A2CF-DAA48CEA768C Q35046419-C076470F-3B0B-4BD1-9B7E-25F0FFA2D467 Q35781606-AC0704E3-BD64-4F11-A1AC-C846C73061D2 Q35805954-310A96CD-6354-4E07-BBE2-4D229EB6DF79 Q35919433-89204F54-2E68-4CA8-98FB-94550AABD6C7 Q35925357-45FB4900-325F-4A07-B12F-76EEBD1166F7 Q36423321-8773567D-D05E-4C33-A98C-62D83F3DBC17 Q36711106-8AF99F66-D1FB-4A55-9574-8C6C1F2FBCEC Q36712237-6060C7C1-EE30-45F5-A4ED-4B98035D6B6F Q36731548-AFA051F6-85A3-412D-817F-F9498DB98F33 Q36743890-4FD8E94B-2D25-4A53-A731-B2AC62D274FA Q36772290-0BC3A75F-707A-496B-824B-476FD65FE648 Q37263875-110AEB9F-8E52-48B6-A74C-87411793E597 Q37326935-165FD7B1-8BC7-4FEA-9335-95BB05BE9C55 Q37362740-76C42463-D9AC-4B56-92E5-C0D9647D4B9D Q37395127-93CD7FBA-4AC0-441F-845B-93240400E021 Q37629047-57480897-0465-476C-8B5E-1B69D0634C6C Q37689190-079551FF-8963-4931-B179-D0EB8C064084 Q37785802-1DFE7D31-CD4F-4F60-9F0B-68A4BC1B8323 Q38017661-B202B8C2-48AB-473D-B199-D103BC14F694 Q38058381-ADA8027A-F660-4B0F-A570-613413881759

P2860

Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators

http://www.wikidata.org/entity/Q28143758

description

2000 nî lūn-bûn

@nan

2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Ligand type-specific interacti ...... h transcriptional coactivators

@ast

Ligand type-specific interacti ...... h transcriptional coactivators

@en

Ligand type-specific interacti ...... h transcriptional coactivators

@nl

type

label

Ligand type-specific interacti ...... h transcriptional coactivators

@ast

Ligand type-specific interacti ...... h transcriptional coactivators

@en

Ligand type-specific interacti ...... h transcriptional coactivators

@nl

prefLabel

Ligand type-specific interacti ...... h transcriptional coactivators

@ast

Ligand type-specific interacti ...... h transcriptional coactivators

@en

Ligand type-specific interacti ...... h transcriptional coactivators

@nl

P1433

Q28143758-18D2ED18-6DD3-430F-BDA7-9A1DE59EFC65

P1476

Q28143758-6B90FF0D-0B93-4251-A238-00945C024B1A

P2093

Q28143758-1F32E2A8-CAEE-483F-9D3D-E3505A1D2B3A

Q28143758-2A831DE1-00C0-423F-9DB2-B352197B643F

Q28143758-2B6EF9F7-5091-4EA6-AB02-211F76757749

Q28143758-97CA7AFB-B658-430F-8A5B-41942B3FA2E0

Q28143758-B61E165E-8136-4FAD-AF43-931CE8029B03

Q28143758-CA62EDFE-1646-4E92-97A1-0E62C9FB70F2

P304

Q28143758-5898296B-E179-4980-97EB-F2D7420FC08C

P31

Q28143758-3A86D52E-CD98-4151-9D86-19493154658B

P3181

Q28143758-CD4DC356-F954-4658-968E-0A9ADE6F4755

P356

Q28143758-D6F477F8-FCE3-4D5B-BBCF-BA8421323BEF

P407

Q28143758-C8B39C3D-DF70-41EF-AA79-3CCDEEB33A70

P433

Q28143758-88862C7E-F42E-472D-8BE8-33752F97FDD6

P478

Q28143758-DD294213-1140-42B2-9848-B395326E1935

P577

Q28143758-6B58000A-D0A9-4D5F-BA2F-779937FC8EC1

P698

Q28143758-FC3DC7FD-2CD0-4547-8139-2FCB54C9B85C

P3181

P356

P1433

Journal of Biological Chemistry

P1476

Ligand type-specific interacti ...... h transcriptional coactivators

@en

P2093

A Murayama

http://www.w3.org/2001/XMLSchema#string

K Takeyama

http://www.w3.org/2001/XMLSchema#string

M Suzawa

http://www.w3.org/2001/XMLSchema#string

S Kato

http://www.w3.org/2001/XMLSchema#string

Y Kodera

http://www.w3.org/2001/XMLSchema#string

Y Masuhiro

http://www.w3.org/2001/XMLSchema#string

P304

33201-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4196568

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.C000517200

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

275

http://www.w3.org/2001/XMLSchema#string

P577

2000-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10944516

http://www.w3.org/2001/XMLSchema#string